Ernexa Therapeutics Inc. (ERNA) KPIs and segments
Close on Nov 11, 2026Market cap $3.15MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Ernexa Therapeutics's business
Ernexa Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subscription Revenue($M) | 1.10 | 1.05 | 0.73 | 2.00 | 2.92 | 3.72 | 3.80 | 3.83 | 3.92 | 4.01 | 4.04 | 4.07 | |
Other Revenue($M) | 0.07 | 0.05 | 0.00 | 0.38 | 0.71 | 0.85 | 0.83 | 0.79 | 0.84 | 0.84 | 1.02 | 1.02 | |
Hardware Revenue($M) | 0.01 | 0.38 | 0.03 | 0.02 | 1.54 | 0.01 | 0.60 | 0.21 | 1.16 | 1.16 | 0.59 | 0.68 | |
United States($M) | 1.09 | 1.42 | 0.72 | 2.25 | 5.01 | 4.42 | 5.06 | 4.66 | 5.75 | 5.83 | 5.48 | 5.59 | |
Canada($M) | 0.09 | 0.06 | 0.03 | 0.15 | 0.16 | 0.16 | 0.16 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2021-03-11.
See a number that looks wrong?